11 Common Ovarian Cancer Myths Vs. Facts

September 19, 2026

11 Common Ovarian Cancer Myths Vs. Facts

Ovarian cancer myths cost women time. Misinformation is the norm, not the exception. In one research study, only 5.1% of women correctly identified most common myths about ovarian cancer as false, and researchers found those beliefs pull attention away from real risk factors.

Why Myths About Ovarian Cancer Are Especially Costly

Ovarian cancer has no reliable screening test for the general population. That single fact makes this disease unusually dependent on awareness. When there is no test to catch what you miss, what you believe becomes your first line of defense.

The numbers reflect the gap. According to data from the National Cancer Institute, only 22% of ovarian cancers are diagnosed while still confined to the ovary. The five-year relative survival rate at that localized stage is 91.9%. For the 54% diagnosed after the cancer has metastasized, it drops to 31.5%.

That spread is where the myths do their damage. 

11 Common Myths About Ovarian Cancer, Debunked

Below are common myths about ovarian cancer, and what the evidence actually shows.

Myth 1: A Pap smear screens for ovarian cancer.

This is the most persistent myth in the entire category, and it gives women false reassurance at exactly the wrong moment.

A Pap test collects cells from the cervix. It screens for cervical cancer and precancerous cervical changes. To be clear: a Pap test cannot reliably detect ovarian cancer. 

There is currently no standard screening test for ovarian cancer for women at average risk. A normal Pap result tells you nothing about your ovaries.

Myth 2: Ovarian cancer is a silent killer with no symptoms.

The “silent killer” label has done real harm. It tells women there is nothing to notice, so they stop noticing.

Ovarian cancer does produce symptoms. They are just vague, and they mimic conditions of more common benign conditions. Bloating. Pelvic or abdominal pain. Feeling full quickly. Needing to urinate more often or more urgently.

The distinguishing feature is not severity. It is persistence. Symptoms that are new for you, that keep showing up, and that do not resolve over two to three weeks deserve evaluation. A more accurate label would be “subtle,” not “silent.” 

Stay informed

Sign up to receive vital updates through email, and learn how you can get involved.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Myth 3: Only older women get ovarian cancer.

Statistically, ovarian cancer skews older. About half of diagnoses occur in women 63 or older, per the American Cancer Society. But “skews older” is not “only older,” and the difference matters enormously to the women on the other side of it.

Research shows roughly 10% of new ovarian cancer diagnoses occur in women under 45. Break that down and 4.9% are women aged 20 to 34.

This is where subtype matters. High-grade serous ovarian cancer primarily affects older women. Low-grade serous ovarian cancer does not. At Not These Ovaries, we focus on low-grade serous ovarian cancer and borderline ovarian cancer precisely because they strike younger, with a median age around 45.  

The myth that this is an older woman’s disease is a direct contributor to delayed diagnosis in young patients. Read more about LGSOC in young women and why the delay happens.

Myth 4: You can check yourself for an ovarian cancer lump.

Breast self-exams gave many women an opportunity to screen for breast cancer in their own home. 

Your ovaries sit deep in the pelvis, behind muscle, bone, and fat. A pelvic mass large enough to feel through the abdominal wall is generally advanced. 

You cannot reliably self-examine internal pelvic organs. And it isn’t only a problem for patients. During a routine pelvic exam, doctors perform what’s called a bimanual exam, pressing on the lower abdomen with one hand while feeling the uterus and ovaries internally with the other. 

Even in trained hands, this exam has low sensitivity and specificity for ovarian cancer. It can miss tumors that are there and flag findings that turn out to be benign. That’s why a pelvic exam on its own isn’t considered an effective tool for ovarian cancer screening.

What you can do:

  • Notice changes in how your abdomen looks and feels, including persistent swelling or a waistband that suddenly does not fit
  • Check external areas like the groin crease for surface bumps or swollen lymph nodes
  • Track symptoms with dates so you can show a doctor a pattern rather than a vague complaint

Finding an internal mass usually takes imaging, such as an ovarian cancer ultrasound or a CT scan, ordered by a doctor who takes your symptoms seriously.

Myth 5: Mobile phones, microwaves, and plastic bottles cause ovarian cancer.

These circulate constantly, and they are among the least-recognized false beliefs. In the myths study mentioned above, mobile phone use was the myth women were least likely to identify as incorrect, with only 24.9% recognizing it as false.

The physics here is clear: cell phones, Wi-Fi routers, and microwave ovens emit non-ionizing radiation. The National Cancer Institute states that non-ionizing electromagnetic fields cannot damage DNA or cells directly. Cancer begins with genetic damage. Non-ionizing radiation does not have enough energy to cause it.

Worrying about your phone is worrying about the wrong thing. Your attention is better spent on documented ovarian cancer risk factors.

Myth 6: You are only at risk if ovarian cancer runs in your family.

Family history raises risk substantially. It does not define it.

Up to 25% of ovarian cancers are part of family cancer syndromes caused by inherited mutations. Read that from the other direction: at least 75% of cases occur in women without a known inherited syndrome.

Most women diagnosed with ovarian cancer had no family history that would have flagged them. “No cancer in my family” is not protection, and it should never be the reason a persistent symptom goes unexamined.

Myth 7: A hysterectomy eliminates your ovarian cancer risk.

This one hinges on a definition most people get confused about. 

A hysterectomy removes the uterus. The terms “total” and “subtotal” refer to the cervix, not the ovaries. If your ovaries were left in place, they remain capable of developing cancer.

Removing the ovaries and fallopian tubes, a bilateral salpingo-oophorectomy, lowers risk dramatically. Even then, it is still possible to develop ovarian cancer after the surgery, because primary peritoneal cancer can arise from related tissue lining the abdomen. The risk becomes very small. It does not become zero.

If surgery is part of your path, understand the distinctions between oophorectomy vs. hysterectomy before you decide. 

Myth 8: An ovarian cyst means cancer is coming.

Ovarian cysts are common. Most are functional cysts tied to the menstrual cycle, and most resolve without any treatment at all.

Cysts are not precancerous lesions. They generally require removal only when they cause symptoms, grow, or show concerning features on imaging. Age, symptoms, and risk factors determine what evaluation makes sense.

That said, a cyst and a tumor are not the same thing, and telling them apart is a clinical job, not a self-diagnosis job. Learn what causes ovarian cysts and how doctors distinguish an ovarian cyst vs tumor.

Myth 9: Ovarian cancer is always caught too late.

The majority of cases are diagnosed at advanced stages. That is true, and it is why our research funding exists. 

Roughly one in five ovarian cancers is caught while still localized. Early detection happens, most often when a woman recognizes a symptom pattern, pushes for evaluation, and gets a clinician who takes her seriously.

Progress is measurable. According to an American Cancer Society analysis, the U.S. ovarian cancer death rate fell 33% between 1976 and 2015, from 10.0 to 6.7 deaths per 100,000 women. And that progress hasn’t stalled. A study presented at the 2025 ASCO Annual Meeting found that after a brief rise in the early 2000s, ovarian cancer deaths have been declining since 2003.

Myth 10: A diagnosis means you will never have children.

Treatment can affect fertility, sometimes permanently. But an ovarian cancer diagnosis is not automatically the end of the conversation about having children.

Fertility-sparing surgery is a real option for some patients, particularly those with early-stage disease or borderline tumors. Egg and embryo freezing exist. So does surrogacy.

The critical variable is timing. These conversations need to happen before treatment begins, which means raising them early even when everything feels urgent. Start with our guide to ovarian cancer and pregnancy to understand the options.

Myth 11: Nothing you do changes your risk.

There is no guaranteed way to prevent ovarian cancer. We say that plainly, because pretending otherwise would be dishonest.

But “no guarantee” is not “no influence.” Several factors are associated with reduced risk, including oral contraceptive use, pregnancy, and breastfeeding. Surgical options like tubal ligation and opportunistic salpingectomy reduce risk meaningfully for some women.

Knowing your genetic status, tracking your symptoms, and seeing the right specialist all shift your odds. 

What Accurate Information Buys You

Debunking myths about ovarian cancer is not an academic exercise. It means advocating for yourself when the first answer does not fit what your body is telling you.

Remember: action and understanding save lives. Correcting what people believe is where both begin.

 

Have questions? Ask Hope

Hope is a conversational AI that can help you answer your questions about ovarian cancer and our charity. Click Ask Hope to start a chat session.



Recommended Reading